Standard Family Office’s Jazz Pharmaceuticals JAZZ Stock Holding History

Standard Family Office’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-11	Closed	-$2K	–	598
2021 Q1	$2K	Hold	11	–	–	﹤0.01%	435
2020 Q4	$2K	Buy	+11	New	+$1.64K	﹤0.01%	439

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.22B AUM 26.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Standard Family Office's JAZZ Position: Q2 2021 in Review

Standard Family Office sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2021, closing a stake of 11 shares — an estimated $2K sold.

Standard Family Office first reported a position in JAZZ in Q4 2020 and held it in 2 quarters. The position peaked at $2K in Q1 2021. 505 funds tracked by Wall St. Rank hold JAZZ as of Q2 2021.

Standard Family Office reported no remaining Jazz Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
Standard Family Office sold 11 Jazz Pharmaceuticals shares in Q2 2021, an estimated $2K.
Standard Family Office first reported a position in Jazz Pharmaceuticals in Q4 2020 and held it in 2 quarters.
Standard Family Office's Jazz Pharmaceuticals position peaked at $2K in Q1 2021.
505 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2021.

Based on Standard Family Office's 13F filing for Q2 2021, filed 13 Aug 2021.